GROGAN DONNA ROY bought CCCC
April 1, 2026 · Form 4 insider transaction
GROGAN DONNA ROY bought 5,370 shares of C4 Therapeutics, Inc. at $2.70 per share, a transaction worth $14.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,370
Price
$2.70
Total value
$14.5K
InsiderGROGAN DONNA ROY
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after71,512
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.; The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026.